Anteris Technologies Global (AVR) Gains from Investment Securities (2024 - 2025)
Anteris Technologies Global (AVR) reported Gains from Investment Securities of -$83000.0 for Q4 2025, up 3.49% year-over-year from -$80202.2 in Q4 2024, and up 3.49% quarter-over-quarter from -$86000.0 in Q4 2024.
Anteris Technologies Global (AVR) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Anteris Technologies Global (AVR) has 2 years of Gains from Investment Securities data on file, last reported at -$83000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$83000.0, up 3.49% year-over-year; the trailing twelve-month figure through Jun 2024 was $475000.0 (changed N/A YoY), and the FY2025 annual result was $52750.0, down 68.59% from the prior year.
- Gains from Investment Securities rose to -$83000.0 in Q4 2025 per AVR's latest filing, from -$86000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $475000.0 in Q2 2024 and troughed at -$86000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -83,000.00 |
| Dec 31, 2025 | -83,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |